评论
打印
A Japanese firm has been ordered to recall dietary supplement pills after deaths among users.
因客户服用膳食补充剂后死亡，日本一家公司已被勒令召回相关产品。
Kobayashi Pharmaceutical said it was bringing back several products to avoid further harm.
这家名为小林制药的企业表示，为了避免伤害情况进一步扩大，他们正在召回几款产品。
All contain red yeast rice, or "beni koji".
这些产品都含有红曲米，也就是“beni koji”。
It contains a mold said to help lower cholesterol, but also used as colouring.
红曲米中含有一种据说有助于降低胆固醇的霉菌，但也可用作着色剂。
Japanese Chief Cabinet Secretary Yoshimasa Hayashi said the government was closely monitoring the numbers of those affected:
日本内阁官房长官林芳正表示，政府正在密切关注受影响的人数。
"We have been made aware of a further fatal event concerning products containing beni koji manufactured by Kobayashi Pharmaceutical,
“我们已经获悉了另一起致命事件，涉及小林制药生产的含有红曲米的产品，
bringing the total deaths to two, as well as 106 related hospitalizations."
目前总死亡人数为2人，106人住院治疗。”
Local media reports say online sales of the affected Kobayashi products have also been halted in China.
当地媒体报道称，受影响的小林制药的产品，目前也已停止在中国网上销售。
The Osaka-based firm says it is investigating whether the products caused kidney damage.
这家总部位于大阪的公司表示，正在调查这些产品是否会对肾脏造成损害。
It has urged 52 other firms to recall products including tofu that contain beni koji that it supplied.
小林制药已敦促其他52家企业召回其供应的产品，包括含有红曲米的豆腐。
Shares in the firm are down 20% since Friday, when it first did a voluntary recall.
自上周五首次主动召回产品以来，该公司股价下跌了20%。
